Webinars on demand

Comprehensive genomic profiling assays provide extensive coverage of variants and immunotherapy biomarkers and increasingly enable physicians to provide cancer patients with more informed treatments.

Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies.

Is your lab ready for inspection? If not, how much time – and how much work – would it take to get there?

This webinar provides an overview of the key factors to consider when adopting a digital pathology solution and the benefits of digitization.

This webinar will focus on user experiences using the Ultivue InSituPlex fluorescence multiplex IHC platform.

This webinar will review practical considerations for the preanalytical phase and explore the aspects that pathology may impact.

With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue.

Join editor Michael Schubert, along with representatives from Proscia and Hamamatsu, in this educational webinar that explains the growing need for pathologists to collaborate remotely.

As part of the College’s International Pathology Day (IPD) celebrations, the College has partnered with The Pathologist to host this one-day event.

After the transition of our pathology lab to a fully digital workflow, we began setting up new, more accurate workflow analyses.

In this webinar, Albrecht Stenzinger will discuss the principles of using nextgeneration sequencing (NGS) to identify the number of genetic alterations in a tumor.

This webinar is a “must see” for anyone interested in PD-1/PD-L1 targeted immunotherapy and quantitative methods for biomarker assessment in immuno-oncology.